We are excited to share that Tiefenbacher API + Ingredients has been awarded the EcoVadis Silver Medal!
EcoVadis is the world’s largest provider of business sustainability ratings. The EcoVadis sustainability assessment methodology is an evaluation of how well a company has integrated the principles of Sustainability/CSR into their business and management system. The Sustainability Scorecard illustrates performance across 21 indicators in four themes:
- Environment
- Labor and human rights
- Ethics
- Sustainable procurement
The award of the silver medal places our company among the top 15% of companies assessed by EcoVadis in the past 12 months – we even reached the 90th percentile! Thanks a lot to all colleagues at Tiefenbacher API + Ingredients who contribute to this advanced sustainability performance!
We, at TIEFENBACHER GROUP, know that our responsibility as a global healthcare company goes beyond medicine. We understand sustainability as behaving responsibly towards society and our planet – in our day-to-day work. That’s why we will continuously strive to achieve our sustainability goals!
TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).
For more information about our finished dosage (FDF) forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDF) including highly potent drugs as well as medical devices and e-health-solutions. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products (including highly potent drugs) and e-health-solutions for global markets, please contact us by email at info@tiefenbacher.com or visit us on www.tiefenbachergroup.com
